Reckitt Benckiser Group plc is a UK-headquartered multinational consumer goods company specializing in health, hygiene and nutrition products. The company develops, manufactures and markets a wide array of well-known brands such as Dettol, Lysol, Durex, Nurofen, Mucinex, Strepsils, Enfamil, Boost and Air Wick. Its health segment addresses cold and flu, pain relief, gastrointestinal and vitamin supplements, while the hygiene division offers surface cleaning, water purification and sexual wellbeing products. The nutrition segment focuses on infant formula, protein supplements and medical nutrition solutions.
Tracing its roots back to the founding of Reckitt & Sons in Hull, England, in 1840, the modern Reckitt Benckiser Group was formed through the merger of Reckitt & Colman and Benckiser in 1999. Today the company’s products are sold in more than 200 markets and it operates manufacturing and research facilities across the Americas, Europe, Asia Pacific, Africa and the Middle East. Reckitt is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index, with American Depositary Receipts trading over the counter under the symbol RBGLY.
Under the leadership of Chief Executive Officer Laxman Narasimhan, who took the helm in 2021, Reckitt continues to invest in innovation, digital capabilities and sustainability. The company has set targets to reduce plastic packaging, lower carbon emissions and improve access to essential health and hygiene products in underserved communities. Guided by a global executive team and regional management structure, Reckitt seeks to leverage its brand portfolio and R&D pipeline to drive long-term growth in both developed and emerging markets.
AI Generated. May Contain Errors.
Free RBGLY Stock Alerts